Literature DB >> 8272197

The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline.

I A Paterson1.   

Abstract

2-Phenylethylamine (PE) is an endogenous brain amine which produces sympathomimetic responses and potentiates cortical neuron responses to noradrenaline (NA). In order to examine further the mechanism of action of PE, extracellular recordings were made of the activity of single neurones in the cerebral cortex in urethane-anesthetized rats. Sympathomimetic responses to PE were blocked by pretreatment with reserpine, reserpine plus alpha-methyl-p-tyrosine and desipramine. It is concluded that the sympathomimetic responses to PE are indirect. 2-Phenylethylamine potentiated cortical neuron responses to electrical stimulation of the locus coeruleus in a dose-dependent manner. This was seen when PE was given systemically (with as little as 1 microgram/kg) and iontophoretically. The effects of PE were not reproduced by its metabolite phenylacetic acid or its putative metabolite phenylethanolamine. Iontophoretic applications of PE (0-6 nA, 2-5 minutes) potentiated cortical neuron responses to iontophoretically applied NA, without affecting the spontaneous firing rate, or the responses to iontophoretically applied GABA or acetylcholine. This effect of PE was not blocked by pretreatment with alpha-methyl-p-tyrosine or desipramine, and was potentiated by pretreatment with reserpine and reserpine plus alpha-methyl-p-tyrosine. It is probable that the ability of PE to modulate neuronal responses to NA does not involve the presynaptic NA terminal or endogenous NA and it is likely that PE acts directly to increase the efficacy of NA. These findings are consistent with the hypothesis that the physiological role of PE is to modulate catecholaminergic transmission within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272197     DOI: 10.1007/bf00975055

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.

Authors:  H C Sabelli; A J Vazquez; D Flavin
Journal:  Psychopharmacologia       Date:  1975-05-28

2.  Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

Authors:  M HOLZBAUER; M VOGT
Journal:  J Neurochem       Date:  1956-05       Impact factor: 5.372

3.  Serotonergic properties of beta-phenethylamine in rats.

Authors:  R S Sloviter; J D Connor; E G Drust
Journal:  Neuropharmacology       Date:  1980-11       Impact factor: 5.250

4.  The determination and distribution of 2-phenylethylamine in sheep brain.

Authors:  G P Reynolds; M Sandler; J Hardy; H Bradford
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

5.  Selective effects of phenylethylamine on central catecholamines: a comparative study with amphetamine.

Authors:  F Karoum; S G Speciale; L W Chuang; R J Wyatt
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

6.  Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat.

Authors:  P H Wu; A A Boulton
Journal:  Can J Biochem       Date:  1975-01

7.  The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices.

Authors:  L E Dyck; C R Yang; A A Boulton
Journal:  J Neurosci Res       Date:  1983       Impact factor: 4.164

8.  beta-Phenylethylamine enhances single cortical neurone responses to noradrenaline in the rat.

Authors:  I A Paterson; A A Boulton
Journal:  Brain Res Bull       Date:  1988-02       Impact factor: 4.077

9.  Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs.

Authors:  H E Shannon; C M Degregorio
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

10.  The potentiation of cortical neurone responses to noradrenaline by beta-phenylethylamine: effects of lesions of the locus coeruleus.

Authors:  I A Paterson
Journal:  Neurosci Lett       Date:  1988-04-22       Impact factor: 3.046

View more
  6 in total

1.  Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.

Authors:  Ada Ledonne; Mauro Federici; Michela Giustizieri; Mauro Pessia; Paola Imbrici; Mark J Millan; Giorgio Bernardi; Nicola B Mercuri
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  The effects of pargyline and 2-phenylethylamine on D1-like dopamine receptor binding.

Authors:  Mark D Berry
Journal:  J Neural Transm (Vienna)       Date:  2010-12-30       Impact factor: 3.575

3.  Molecular dynamics-based simulation of trace amine membrane permeability.

Authors:  Mark D Berry; Jarrod Nickel; Mithila R Shitut; Bruno Tomberli
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

Review 4.  Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.

Authors:  Ruyan Wu; Jun-Xu Li
Journal:  CNS Drugs       Date:  2021-11-12       Impact factor: 5.749

Review 5.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

Review 6.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.

Authors:  Yue Pei; Aman Asif-Malik; Juan J Canales
Journal:  Front Neurosci       Date:  2016-04-05       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.